Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02994693 · ClinicalTrials.gov registry record
Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy
A clinical trial of Barrett Esophagus and Barretts Esophagus With Dysplasia, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT02994693: Active study of Barrett Esophagus and Barretts Esophagus With Dysplasia, sponsored by Massachusetts General Hospital.
NCT02994693 is a study of Barrett Esophagus and Barretts Esophagus With Dysplasia that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 100 participants, below the 3,562-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02994693, a study of Barrett Esophagus and Barretts Esophagus With Dysplasia, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research is to determine the natural history of Barrett's esophagus (BE) using tethered capsule endomicroscopy (TCE) in participants undergoing surveillance endoscopy.
Primary Outcome
An investigator will assess the quality of the recorded images and movies obtained with each exam after imaging has been completed. They will assess how the images change over time.
Conditions Studied
Interventions
- DEVICE OFDI capsule imaging
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-12 |
| Est. Completion | 2029-12 |
What the registry record for NCT02994693 still lists
NCT02994693 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,562-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which OFDI capsule imaging is the first listed.
NCT02994693 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02994693 about?
NCT02994693 is a clinical study titled "Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy". The goal of this research is to determine the natural history of Barrett's esophagus (BE) using tethered capsule endomicroscopy (TCE) in participants undergoing surveillance endoscopy.
What is the current status of trial NCT02994693?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2016-12. Estimated completion is 2029-12.
What conditions does trial NCT02994693 study?
This clinical trial studies the following conditions: Barrett Esophagus, Barretts Esophagus With Dysplasia.
What interventions are being tested in trial NCT02994693?
The interventions under investigation include: OFDI capsule imaging (DEVICE).
Who is sponsoring clinical trial NCT02994693?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02994693 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02994693's enrollment target sits among peer trials
100 21st of 32 higher than 11 of 32 other Barrett Esophagus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Barrett Esophagus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING · NA
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RECRUITING
-
Longitudinal Oral Microbiome Sampling for BE
RECRUITING
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Non-Endoscopic Detection of Barrett's Esophagus Using Methylation Biomarkers on EndoSign® Cell Collection Device Samples
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia